| Page 32 | Cafepharma

You are here

Primary tabs

FDA Accepts sNDA for Lynparza for Maintenance Therapy in Advanced Ovarian Cancer and Grants Priority Review

Post date: November 12, 2018 - 9:54am

Prevencio Releases Study of AI Powered Blood Test to Predict Acute Kidney Injury Risk

Post date: November 12, 2018 - 9:51am

Harpoon Therapeutics Banks $70M Series C Financing

Post date: November 11, 2018 - 9:33pm

Second aMoon Venture Fund Nears $750 million Cap

Post date: November 9, 2018 - 10:37am

AI-Powered Hearing Aid Wins Two 2019 CES Innovation Awards

Post date: November 9, 2018 - 9:48am

Myonexus Therapeutics Starts Trial of First-Ever Gene Therapy for Rare Type of Muscular Dystrophy

Post date: November 8, 2018 - 9:56am

Vedanta Biosciences Announces Preclinical Data on Microbiome-Derived Immuno-Oncology Candidate

Post date: November 7, 2018 - 11:15pm

Synlogic Presents Preclinical Data from First Synthetic BioticTM Clinical Candidate in Immuno-Oncology

Post date: November 7, 2018 - 11:05pm

SkinBiotix Technology Generates Positive Data in First Two Elements of its Human Study

Post date: November 7, 2018 - 10:53pm

Rebiotix and Microbiome Insights Collaborate on a Microbiome IBD Diagnostic Tool to Aid Clinical Development

Post date: November 7, 2018 - 1:02pm

Pages